10 Best Biotech and AI Stocks To Buy According To Quant Billionaire Jim Simons
Euclidean Capital is the family office of billionaire hedge fund manager James "Jim" Simons.
Hedge Fund - Euclidean Capital
Get Email AlertsJim Simons Bio, Returns, AUM, Net Worth
Manager biography is currently missing.
Fund Profile
Filing Period:
| Fund Name: | Euclidean Capital |
| Manager | Jim Simons |
| Portfolio Value | $888,536,292 |
| Change This QTR | +0.97% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | SPY | 917,141 | $435,926,289 | +273% | 49.06% | ||
| 2. | GLD | 1,390,000 | $265,726,300 | +31% | 29.9% | ||
| 3. | Ishares Tr | 2,425,144 | $118,371,279 | 13.32% | |||
| 4. | RAPT | 657,899 | $16,348,790 | 1.83% | |||
| 5. | ALEC | 1,307,858 | $10,436,707 | 1.17% |
Latest 13D & 13G Filings
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2022-02-14 | ||||
| 2021-10-18 | ||||
| 2021-05-07 |
News, Interviews and Investor Letters
10 Pharmaceutical Stocks to Buy According to Jim Simons’ Euclidean Capital
In this article, we reviewed Jim Simons' investment strategy, historical performance, and family office portfolio.
11 Best Pharma and Biotech Stocks to Buy According to Jim Simons' Euclidean Capital
In this article, we will discuss the 11 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital.
5 Best Pharma and Biotech Stocks to Buy According to Jim Simons' Euclidean Capital
In this article, we discuss the 5 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital.
